Tilray Brands’ Unit Tilray Medical Secures Key Regulatory Approval For In-House Testing At Portugal Facility

10/13/2026
Impact: 75
Healthcare

Tilray Medical, a division of Tilray Brands, has received regulatory approval from Portugal's INFARMED for its quality control laboratory at its EU-GMP-certified facility in Cantanhede. This approval allows for in-house microbiological and chemical/physical testing, enhancing product release capabilities and positioning the facility as a key hub for pharmaceutical-grade medical cannabis supply in international markets. The move is expected to strengthen Tilray's European production platform amid increasing demand for medical cannabis.

AI summary, not financial advice

Share: